Ixchelsis reports positive phase IIa results for IX-01 as treatment of premature ejaculation Jan. 26, 2016 No Comments
Medifocus engages Kapec Design Group as lead designer of next generation of Prolieve Jan. 14, 2016 No Comments
Astellas Pharma and Kotobuki Pharmaceutical present IRAP and P-LAP inhibitors Dec. 22, 2015 No Comments
DMX-200 drug combination given FDA orphan designation for focal segmental glomerulosclerosis Dec. 15, 2015 No Comments
RSS